Skip to main content
Equibles

NATIONAL BANK OF CANADA /FI/

Bank

Position in ABEO — Abeona Therapeutics Inc.

CIK 926171 MONTREAL, A8
Back to ABEO Full portfolio

Position in ABEO

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$3,090,000
+$850,000 QoQ
Shares Held
500,000
0.0% QoQ
Ownership
0.874%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 125 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIONAL BANK OF CANADA /FI/ holds $632,429,861 across 151 Biotechnology names. ABEO ranks #11 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 1,096,025 $205,263,562
2 MRNA
Moderna, Inc.
 1,424,802 $99,778,883
3 ROIV
Roivant Sciences Ltd.
 2,773,874 $98,167,400
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 172,898 $85,883,622
5 REGN
Regeneron Pharmaceuticals, Inc.
 125,812 $78,448,813
6 ALNY
Alnylam Pharmaceuticals, Inc.
 52,467 $15,794,140
7 GPCR
Structure Therapeutics Inc.
 215,800 $11,581,986
8 ABCL
AbCellera Biologics Inc.
 1,233,014 $9,679,159

All Filings in ABEO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,090,000 500,000
2026-03-31 $2,240,000 500,000